Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02125786 : A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
PhasePhase 2
AgesMin: 1 Year Max: 21 Years
Inclusion Criteria:

- Progressive intracranial ependymoma after prior focal irradiation

- Patients aged 1-21 years at the time of enrollment

- Adequate performance status (ECOG < 3) and research participant does not require
mechanical ventilation

- Interval from start of initial radiation therapy to enrollment > 9 months

Exclusion Criteria:

- Prior craniospinal irradiation

- Pregnant women are excluded from enrollment on this study because radiation therapy is
an agent with the potential for teratogenic or abortifacient effects

- Any patient with both metastatic ependymoma and age < 3 years at the time of
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557